Selection of optimal treatment procedures for non-standard radioactive waste arising from decommissioning of NPP after accident

2016 ◽  
Vol 301 ◽  
pp. 391-401 ◽  
Author(s):  
Roman Strážovec ◽  
Tomáš Hrnčíř ◽  
Martin Lištjak ◽  
Vladimír Nečas
2005 ◽  
Vol 196 (1-3) ◽  
pp. 63-68 ◽  
Author(s):  
Frédérico Garrido ◽  
Aurélie Gentils ◽  
Lionel Thomé

2019 ◽  
Vol 59 (6) ◽  
pp. 612-615
Author(s):  
V. A. Sokolov ◽  
M. D. Gasparyan ◽  
M. B. Remizov ◽  
P. V. Kozlov

Author(s):  
Kazumi Kitayama

In the year 2000, the Japanese geological disposal program for high-level radioactive waste (HLW) moved from the phase of generic research and development into the phase of implementation. Following legislation entitled the “Specified Radioactive Waste Final Disposal Act” (hereafter “the Act”), the Nuclear Waste Management Organization of Japan (NUMO) was established as the implementing organization in October 2000. The assigned activities of NUMO include repository site selection, developing relevant license applications and construction, operation and closure of the repository. To initiate the first stage, NUMO has chosen an “open solicitation” approach for finding candidate sites in the belief that the support of local communities is essential to the success of this highly public, long-term project extending over more than a century. Based on this concept, NUMO announced the start of open solication for volunteer municipalities for selection of Preliminary Investigation Areas to the public on December 19, 2002. This paper describes NUMO’s open solicitation of volunteer municipalities for a potential disposal site.


2020 ◽  
Vol 8 (1) ◽  
Author(s):  
Etika Emaliyawati ◽  
Restuning Widiasih ◽  
Titin Sutini ◽  
Ermiati Ermiati ◽  
Urip Rahayu

Communication among nurses, patients, and families takes an important role in the intensive care unit in which the patients are in critical condition and unable to involve in two-way communication. Research related to effective nurse-patient communication has been done extensively, but the information regarding communication in intensive care unit is still limited. This research aimed to explore nurses’ experiences in the intensive care units in effective communication to patients/patient’s families. This was a qualitative study project with phenomenology approach. The data were collected using the in-depth interview technique approximately 60 minutes involving ten nurses who were selected using the purposive sampling at Al Islam Hospital Bandung. Data were analysed using the Colaizzi method and the results were presented in themes. Based on the nurses’ experiences, four themes were emerged in this study including (1) Nurses’ dilemma of their professionalism and personal issues/matters, (2) Contextual factor affects selection of nurses' communication technique, (3) Barriers in effective communication; difficulties in accompanying families to accept critical patient conditions, care and treatment procedures in the ICU which were complicated, and misunderstanding between nurse-patient and family (4) Compassion and patience are required in nurse-patient communication in ICU. The complex patient/family conditions in the ICU require nurses to choose the appropriate communication technique accompanied by a sense of compassion and patience. Nurses need to improve their ability to communicate effectively in order to lower the barriers in communicating between nurses-patients/families. Recommendations, training and assistance of effective communication become important for nurses in improving services in the Intensive Care Unit.


2017 ◽  
Vol 158 (41) ◽  
pp. 1620-1629
Author(s):  
Tímea Gurbity Pálfi ◽  
Viktória Fésüs ◽  
Csaba Bödör ◽  
Zita Borbényi

Abstract: Chronic lymphoid leukaemia (CLL) has a heterogeneous clinical course depending on many clinical and molecular prognostic markers, which play an important role in the selection of the best treatment option. So far, TP53 disruption is the key prognostic and predictive factor assisting treatment decisions, especially in the era of novel therapies. Asymptomatic patients in early stages of the disease will still benefit from watchful waiting. In the frontline setting, chemoimmunotherapy is still the standard care in the majority of standard risk CLL patients. New classes of drugs like kinase inhibitors and BCL-2 inhibitors (ibrutinib, idelalisib and venetoclax) are the treatment of choice in CLL patients with relapsed/refractory disease, with the exception of high risk disease, where the optimal treatment is frontline ibrutinib monotherapy. In the near future, integrating next generation sequencing into the routine diagnostics would help the development of individual CLL patient management and to choose an optimal treatment strategy. Orv Hetil. 2017; 158(41): 1620–1629.


Sign in / Sign up

Export Citation Format

Share Document